COVID-19 Risk Assessment Agent
COVID-19 Risk Assessment Agent
This AI agent walks patients through a structured COVID-19 risk assessment based on CDC guidelines, evaluating symptoms, exposure history, and pre-existing conditions to recommend next steps. During the height of the pandemic, health systems that deployed digital symptom checkers reduced unnecessary emergency department visits by 40-60%, while ensuring high-risk individuals received timely care guidance. The underlying model — conversational symptom triage that scales without staffing constraints — has proven equally valuable for flu seasons, RSV surges, and emerging infectious disease preparedness. Healthcare organizations that invested in digital front-door triage during COVID-19 now maintain these tools year-round as a core part of their patient access strategy.
COVID-19 Risk Assessment Agent
Digital symptom triage delivers quantifiable value across clinical operations, public health surveillance, and patient experience.
Emergency departments were overwhelmed during COVID-19 surges not because every patient needed emergency care, but because patients had no reliable way to assess their own risk level. Health systems that deployed digital screening reported 40-70% reductions in low-acuity COVID-related ER visits. At an average emergency department visit cost of $2,200, diverting even 100 unnecessary visits per week saves over $11 million annually for a single health system. The AI agent acts as a clinical decision support tool for patients, helping them understand when they genuinely need emergency care versus when home monitoring or a telehealth visit is the appropriate response.
A single triage nurse handles approximately 8-12 screening calls per hour. During peak COVID periods, call volumes at major health systems exceeded 10,000 per day. Scaling phone-based triage to meet that demand would require hiring hundreds of temporary nurses — an impossibility given the concurrent staffing crisis. A conversational AI agent handles unlimited concurrent screenings with zero wait time. Tars healthcare deployments have processed over 60 million conversations across the platform. For public health departments and hospital systems, this means population-scale screening capacity without proportional staffing costs, turning a surge-response bottleneck into an always-available resource.
Every screening interaction generates structured data: symptom prevalence by geography, risk factor distribution, care pathway utilization, and screening volume trends over time. Public health departments using digital triage tools during COVID-19 gained real-time syndromic surveillance capabilities that phone-based screening could never provide. This data informed decisions about testing site placement, resource allocation, and community-level intervention strategies. Post-pandemic, health systems retain these tools for seasonal flu monitoring, RSV surveillance, and preparedness for future infectious disease events, making the initial deployment investment a long-term public health infrastructure asset.
COVID-19 Risk Assessment Agent
features
Purpose-built for healthcare organizations managing population-scale screening during infectious disease events.
The agent follows a structured clinical protocol aligned with CDC screening guidelines for COVID-19. It evaluates primary symptoms (fever above 100.4F, persistent cough, difficulty breathing), secondary symptoms (fatigue, body aches, headache, sore throat, congestion, nausea, diarrhea), and high-risk indicators (age over 65, immunosuppression, chronic respiratory disease, obesity). This is not a generic chatbot asking yes/no questions. The branching logic mirrors the clinical decision trees that triage nurses use, scaled to handle thousands of simultaneous assessments without wait times. During peak COVID surges, nurse triage lines experienced hold times exceeding 45 minutes, making automated pre-screening essential for healthcare access.
Beyond symptoms, the agent assesses epidemiological risk factors that determine testing priority and isolation protocols. It asks about close contact with confirmed COVID-19 cases, attendance at large gatherings, travel to regions with active outbreaks, and workplace exposure in high-risk settings like healthcare facilities, long-term care homes, or correctional institutions. This exposure data, combined with symptom severity, produces a composite risk score that determines care pathway recommendations. During the pandemic, health systems using structured digital pre-screening reported 35% faster triage-to-care times compared to phone-based screening alone.
Infectious disease outbreaks disproportionately impact communities with limited English proficiency and reduced access to healthcare infrastructure. The agent supports deployment in multiple languages and is designed for low-literacy interaction patterns, using simple language, clear multiple-choice options, and visual cues rather than requiring patients to type lengthy responses. The conversational format achieves higher completion rates than static web forms. A 2021 Journal of Medical Internet Research study found that chatbot-based symptom checkers achieved 91% completion rates compared to 67% for equivalent web forms, a difference that translates directly into more patients screened and fewer falling through the cracks.
The agent does not simply tell patients whether they are at risk. It provides specific, actionable next steps based on their assessment results: self-monitoring instructions with a list of warning signs to watch for, a direct link to schedule a telehealth consultation, directions to the nearest testing site with hours and appointment booking, or instructions to call 911 or proceed to the nearest emergency department for severe symptoms. This structured routing reduced unnecessary ER visits during COVID surges — Providence Health reported that their AI-powered symptom checker diverted 70% of low-risk patients away from emergency departments, freeing capacity for patients who actually needed acute care.
COVID-19 Risk Assessment Agent
Deploy a patient-facing symptom triage agent aligned with clinical guidelines in days, not months.
COVID-19 Risk Assessment Agent
FAQs
The agent follows a structured clinical decision tree aligned with CDC guidelines. It evaluates three categories: current symptoms and their severity (fever, cough, shortness of breath, loss of taste/smell), exposure history (close contact with confirmed cases, travel to outbreak areas, high-risk workplace settings), and pre-existing risk factors (age, chronic conditions, immunocompromised status). The combination of these inputs produces a risk classification and a specific care pathway recommendation — from self-monitoring at home to immediate emergency department referral.
Yes. Tars is HIPAA compliant, SOC 2 Type 2 certified, GDPR compliant, and ISO 27001 certified. All patient data collected during the screening conversation, including symptom reports, exposure history, and personal health information, is encrypted in transit and at rest. Tars supports Business Associate Agreements for healthcare organizations that require them. For public health deployments where anonymized aggregate data is sufficient, the agent can be configured to collect screening results without personally identifiable information.
Absolutely. The underlying architecture — conversational symptom collection, risk factor evaluation, and care pathway routing — applies to any condition where structured patient self-assessment can improve triage efficiency. Healthcare organizations have adapted similar agents for influenza screening during flu season, RSV assessment in pediatric populations, monkeypox risk evaluation, and general respiratory illness triage. The clinical decision tree is fully configurable, so updating the agent for a new pathogen or screening protocol requires changing the questions and routing logic, not rebuilding from scratch.
Tars supports over 600 integrations. For COVID-19 screening specifically, common integration patterns include pushing screening results to your EHR via HL7 FHIR-compatible webhooks, logging triage data in Salesforce Health Cloud or HubSpot for follow-up workflows, routing high-risk patients directly into telehealth scheduling systems, and aggregating anonymized results in Google Sheets or data warehouses for surveillance dashboards. Custom API integrations handle any system-specific requirements your health IT team needs.
Healthcare organizations have deployed Tars screening agents in as little as 48 hours during active outbreaks. The agent is configured through a visual editor with no coding required. You define your screening protocol, set up care pathway routing, connect your integrations, and deploy via website embed or standalone link. During the early COVID-19 response, speed of deployment was a critical differentiator — organizations that waited weeks for custom-built solutions missed the window when screening demand was highest.
The agent provides an immediate, personalized recommendation based on the patient's screening results. Low-risk patients receive self-monitoring guidance with clear instructions on warning signs that should prompt them to seek care. Moderate-risk patients are directed to schedule a telehealth consultation or visit a testing site, with links to book appointments or find locations. High-risk patients with severe symptoms receive instructions to contact emergency services or proceed to the nearest emergency department. All results are logged in your connected systems for follow-up, and the agent can trigger automated notifications to care coordinators for high-risk screenings.
Yes, this is one of the primary advantages over phone-based triage. The AI agent handles unlimited concurrent conversations with zero wait time. While a nurse triage line processes 8-12 calls per hour per nurse, the agent can conduct thousands of simultaneous screenings. Tars infrastructure is built for enterprise-scale healthcare deployments, and the platform has processed over 60 million conversations. During a surge event, the agent scales automatically without requiring additional staffing, hardware, or configuration changes.
The agent is not making clinical diagnoses. It is applying the same structured screening protocol that triage nurses follow, using a consistent clinical decision tree that does not vary based on fatigue, call volume pressure, or individual interpretation. Studies published in the Journal of Medical Internet Research found that well-designed symptom checker chatbots achieved triage accuracy comparable to phone-based nurse triage for straightforward screening protocols, with the added advantage of 100% protocol adherence. The agent is designed to identify patients who need clinical evaluation and route them appropriately, not to replace physician diagnosis.
Privacy & Security
At Tars, we take privacy and security very seriously. We are compliant with GDPR, ISO, SOC 2, and HIPAA.
Email - sales@hellotars.com
.png)
%201.png)
%201.png)
